✦ LIBER ✦

Population pharmacokinetic and adverse event analysis of topotecan in patients with solid tumors

✍ Scribed by Mould, D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Population pharmacokinetics of cabazitax

✍ Géraldine M. Ferron, Yang Dai, Dorothée Semiond 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 429 KB

Population pharmacokinetic analysis of 1

✍ Aregbe, Abdulateef O.; Sherer, Eric A.; Egorin, Merrill J.; Scher, Howard I.; So 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 215 KB

Pharmacokinetic analysis of irinotecan p

✍ Crystal S. Denlinger; Rebecca Blanchard; Lu Xu; Coen Bernaards; Samuel Litwin; C 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 386 KB

Phase I study of docetaxel and topotecan

✍ Katherine H. Tkaczuk; William C. Zamboni; Nancy S. Tait; Barry R. Meisenberg; L. 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 103 KB

Phase I clinical and pharmacokinetic stu

✍ C.-P. Schneider; U. Merkel; U. Grübner; R. Kath; K. Höffken; A. Hoffmann 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 89 KB

420 Population pharmacokinetic and pharm

✍ B. Mistry; O. Majid; C. Farrell; D. Rossignol; C. Okereke; J. Fan; Z. Hussein; A 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB